Literature DB >> 18184961

A gain-of-function mutation in the HIF2A gene in familial erythrocytosis.

Melanie J Percy1, Paul W Furlow, Guy S Lucas, Xiping Li, Terence R J Lappin, Mary Frances McMullin, Frank S Lee.   

Abstract

Hypoxia-inducible factor (HIF) alpha, which has three isoforms, is central to the continuous balancing of the supply and demand of oxygen throughout the body. HIF-alpha is a transcription factor that modulates a wide range of processes, including erythropoiesis, angiogenesis, and cellular metabolism. We describe a family with erythrocytosis and a mutation in the HIF2A gene, which encodes the HIF-2alpha protein. Our functional studies indicate that this mutation leads to stabilization of the HIF-2alpha protein and suggest that wild-type HIF-2alpha regulates erythropoietin production in adults. 2008 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184961      PMCID: PMC2295209          DOI: 10.1056/NEJMoa073123

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

1.  Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo.

Authors:  William Y Kim; Michal Safran; Marshall R M Buckley; Benjamin L Ebert; Jonathan Glickman; Marcus Bosenberg; Meredith Regan; William G Kaelin
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

2.  Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis.

Authors:  Mary F McMullin; D Bareford; P Campbell; A R Green; Claire Harrison; Beverley Hunt; D Oscier; M I Polkey; J T Reilly; E Rosenthal; Kate Ryan; T C Pearson; Bridget Wilkins
Journal:  Br J Haematol       Date:  2005-07       Impact factor: 6.998

3.  Oxygen sensing: recent insights from idiopathic erythrocytosis.

Authors:  Frank S Lee; Melanie J Percy; Mary Frances McMullin
Journal:  Cell Cycle       Date:  2006-05-01       Impact factor: 4.534

4.  Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.

Authors:  Erinn B Rankin; Debra F Higgins; Jacqueline A Walisser; Randall S Johnson; Christopher A Bradfield; Volker H Haase
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 5.  Proline hydroxylation and gene expression.

Authors:  William G Kaelin
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

6.  Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development.

Authors:  Donghoon Yoon; Yves D Pastore; Vladimir Divoky; Enli Liu; Agnieszka E Mlodnicka; Karin Rainey; Premysl Ponka; Gregg L Semenza; Armin Schumacher; Josef T Prchal
Journal:  J Biol Chem       Date:  2006-06-19       Impact factor: 5.157

Review 7.  New agents that stimulate erythropoiesis.

Authors:  H Franklin Bunn
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

8.  IOP1, a novel hydrogenase-like protein that modulates hypoxia-inducible factor-1alpha activity.

Authors:  Jianhe Huang; Daisheng Song; Adrian Flores; Quan Zhao; Sharon M Mooney; Leslie M Shaw; Frank S Lee
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

9.  A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis.

Authors:  Melanie J Percy; Quan Zhao; Adrian Flores; Claire Harrison; Terence R J Lappin; Patrick H Maxwell; Mary Frances McMullin; Frank S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

Review 10.  Hypoxia-inducible factors: central regulators of the tumor phenotype.

Authors:  John D Gordan; M Celeste Simon
Journal:  Curr Opin Genet Dev       Date:  2007-01-08       Impact factor: 5.578

View more
  122 in total

1.  Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders.

Authors:  Cynthia M Beall; Gianpiero L Cavalleri; Libin Deng; Robert C Elston; Yang Gao; Jo Knight; Chaohua Li; Jiang Chuan Li; Yu Liang; Mark McCormack; Hugh E Montgomery; Hao Pan; Peter A Robbins; Kevin V Shianna; Siu Cheung Tam; Ngodrop Tsering; Krishna R Veeramah; Wei Wang; Puchung Wangdui; Michael E Weale; Yaomin Xu; Zhe Xu; Ling Yang; M Justin Zaman; Changqing Zeng; Li Zhang; Xianglong Zhang; Pingcuo Zhaxi; Yong Tang Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.

Authors:  Charline Ladroue; David Hoogewijs; Sophie Gad; Romain Carcenac; Federica Storti; Michel Barrois; Anne-Paule Gimenez-Roqueplo; Michel Leporrier; Nicole Casadevall; Olivier Hermine; Jean-Jacques Kiladjian; André Baruchel; Fadi Fakhoury; Brigitte Bressac-de Paillerets; Jean Feunteun; Nathalie Mazure; Jacques Pouysségur; Roland H Wenger; Stéphane Richard; Betty Gardie
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

3.  Clinical utility gene card for: familial erythrocytosis.

Authors:  Kais Hussein; Melanie Percy; Mary Frances McMullin
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

4.  Proteomic dissection of the von Hippel-Lindau (VHL) interactome.

Authors:  Yanlai Lai; Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

Review 5.  The role of the ubiquitin-proteasome system in kidney diseases.

Authors:  Hirotaka Fukasawa
Journal:  Clin Exp Nephrol       Date:  2012-06-09       Impact factor: 2.801

6.  Nonmosaic somatic HIF2A mutations associated with late onset polycythemia-paraganglioma syndrome: Newly recognized subclass of polycythemia-paraganglioma syndrome.

Authors:  Ying Pang; Garima Gupta; Abhishek Jha; Xupeng Yue; Herui Wang; Thanh-Truc Huynh; Aiguo Li; Liping Li; Eva Baker; Emily Chew; Richard A Feelders; Esther Korpershoek; Zhengping Zhuang; Chunzhang Yang; Karel Pacak
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

7.  A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma.

Authors:  Felipe R Lorenzo; Chunzhang Yang; Mark Ng Tang Fui; Hariprasad Vankayalapati; Zhengping Zhuang; Thanh Huynh; Mathis Grossmann; Karel Pacak; Josef T Prchal
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

8.  Erythrocytosis associated with a novel missense mutation in the HIF2A gene.

Authors:  Richard van Wijk; Scott Sutherland; Annet C W Van Wesel; Eric G Huizinga; Melanie J Percy; Marc Bierings; Frank S Lee
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

9.  Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.

Authors:  Aftab Ahmad; Shama Ahmad; Kenneth C Malcolm; Stacy M Miller; Tara Hendry-Hofer; Jerome B Schaack; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

Review 10.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.